GO.
BE.
GOMEKLI comes in capsules or tablets for oral suspension so you can take the medicine as a liquid.
Commercially insured patients may pay as little as $0 copay for GOMEKLI.* See how SpringWorks CareConnections™ can help.
Use the doctor finder tool to locate a healthcare provider who has experience with NF1 near you.
*Terms and conditions apply. Copay program for GOMEKLI and reimbursement for eligible treatment-related costs are subject to annual benefit maximums. To receive the reimbursement of eligible treatment-related expenses, an Explanation of Benefits (EOB) form must be submitted, along with copies of receipts for any payments made. Full terms and conditions are provided during the enrollment process and are available upon request by contacting SpringWorks CareConnections at 844-CARES-55 (844-227-3755).
GOMEKLI (mirdametinib) is a prescription medicine used to treat adults and children 2 years of age and older with neurofibromatosis type 1 (NF1) who have plexiform neurofibromas that cause symptoms and cannot be completely removed by surgery.
It is not known if GOMEKLI is safe and effective in children under 2 years of age.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
See the “Instructions for Use” that come with your medicine for instructions on how to prepare and take GOMEKLI tablets for oral suspension.
It is not known if GOMEKLI is safe and effective in children under 2 years of age.
You are now leaving GOMEKLI.com, a website provided by SpringWorks Therapeutics. This link will take you to a different site to which this Privacy Policy and Terms of Use do not apply.
Tap "Continue" if you are a US Healthcare Professional.